ESPR
ESPR
NASDAQ · Pharmaceuticals

Esperion Therapeutics Inc

$2.55
-0.05 (-1.92%)
As of Mar 22, 10:15 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 11 79%
Hold 2 14%
Sell 1 7%
Price Target
Analyst Price Target +641.6% upside
Low Target $12.50
Average Target $18.91
High Target $21.23
Current Price $2.55
Current
$2.55
Target
$18.91
$12.50 $18.91 avg $21.23
Scenario Analysis
Bear Case
$12.50
390.2%
Low target
Base Case
$18.91
+641.6%
Avg target
Bull Case
$21.23
+732.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.18
-38.9% from high
52-Week Low
$0.69
+268.2% from low
Target vs 52W High
$18.91
+352.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%